Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea

Gyu Hur,Min Seob Song,Sejung Sohn,Hyoung Doo Lee,Gi-Beom Kim,Hwa Jin Cho,Kyung-Lim Yoon,Chan Uhng Joo,Myung Chul Hyun,Chul Ho Kim

Infliximab Treatment for Intravenous Immunoglobulin-resistant Kawasaki Disease: a Multicenter Study in Korea

2019

Gyu Hur
Min Seob Song
Sejung Sohn
Hyoung Doo Lee
Gi-Beom Kim
Hwa Jin Cho
Kyung-Lim Yoon
Chan Uhng Joo
Myung Chul Hyun
Chul Ho Kim

Background and Objectives We investigated the status of infliximab use in intravenous immunoglobulin (IVIG)-resistant Kawasaki disease (KD) patients and the incidence of coronary artery aneurysms (CAAs) according to treatment regimens.

Keywords:

Antibody
Kawasaki disease
Gastroenterology
Cardiology
Infliximab
Diabetes mellitus
Intravenous Immunoglobulins
Internal medicine
Medicine
in patient
treatment regimen
treatment failure
multicenter study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations